Auranofin is a gold complex classified by the World Health Organization as an
antirheumatic agent. It has the brand name Ridaura.
Auranofin is used, with rest and nondrug therapy, to treat rheumatoid arthritis. It
improves arthritis symptoms including painful or tender and swollen joints and ...
Easy to read patient leaflet for auranofin. Includes indications, proper use, special
instructions, precautions, and possible side effects.
Find patient medical information for auranofin oral on WebMD including its uses,
side effects and safety, interactions, pictures, warnings and user ratings.
Feb 25, 2013 ... auranofin (CHEBI:2922) has role immunosuppressive agent ... auranofin (CHEBI:
2922) is a gold coordination entity (CHEBI:33971) ...
AURANOFIN. W. F. KEAN, L. HART and W. W. BUCHANAN. Rheumatic Disease
Unit, McMaster University, 401-1 Young Street, Hamilton, Ontario L8N 1T8, ...
Medscape - Indication-specific dosing for Ridaura (auranofin), frequency-based
adverse effects, comprehensive interactions, contraindications, pregnancy ...
Jan 18, 2016 ... We have loaded auranofin, a gold compound traditionally used for treatment of
rheumatoid arthritis, into PLGA NPs and their efficiency as ...
Auranofin (Ridaura) is an oral medication used to treat rheumatoid arthritis when
other drugs don't work. Learn about its side effects, warnings, and more.
Feb 20, 2015 ... Auranofin has potential as a therapy for a number of diseases including cancer,
neurodegenerative disorders, HIV/AIDS, parasitic infections ...